Log in to save to my catalogue

Midostaurin in Advanced Systemic Mastocytosis

Midostaurin in Advanced Systemic Mastocytosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1801439042

Midostaurin in Advanced Systemic Mastocytosis

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

To the Editor:
Advanced systemic mastocytosis
1
carries a poor prognosis.
2
Midostaurin, an inhibitor of tyrosine kinases, targets KIT mutants associated with mastocytosis.
3
The French National Reference Center for Mastocytosis (CEREMAST) conducted a prospective survey of patients with mastocytosis who were treated with midost...

Alternative Titles

Full title

Midostaurin in Advanced Systemic Mastocytosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1801439042

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1801439042

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc1515403

How to access this item